
1.4
Impact Factor
4.5
CiteScore
Niosome-based delivery systems for olanzapine: Formulation, characterisation, and kinetic evaluation
Recent advances in the treatment of non-alcoholic fatty liver disease with astragaloside IV
Scutellarin mitigates LPS-ATP-induced cardiomyocyte pyroptosis through the inhibition of the NLRP3/caspase-1/GSDMD signalling pathway
, , , , , et
Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists
INFORMATIONS SUR LA REVUE
1.4
Impact Factor
2.4
Five Year Impact Factor
0.54
JCI
4.5
CiteScore
0.398
SJR
0.607
SNIP
24
Google Scholar H5-index
39
Google Scholar H5-median